In contrast, when the expression of TAp63 is decreased in cancer cells, miR-133b expression is downregulated, and RhoA expression is increased, ultimately inhibiting the PI3K/Akt pathway, thus promoting TAp63 expression and TAp63-related apoptosis and inhibiting TAp63-related proliferation. Here, AKT1 is linked to cancer.